fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Advertisment

Sobi to unveil new data at the annual European Association for Haemophilia and Allied Disorders (EAHAD 2025)

Written by | 28 Jan 2025 | Conference Highlights

Sobi will unveil new data at the annual European Association for Haemophilia and Allied Disorders (EAHAD 2025) congress in Milan from the 4th – 7th February, 2025. Outcomes and analyses investigating the effectiveness of Altuvoct and Elocta in adults, adolescents, and children with haemophilia A will be presented, further showcasing Sobi’s commitment to advancing standards of care in haemophilia.

“People with haemophilia can experience bleeding episodes that can cause pain, irreversible joint damage, and life-threatening haemorrhages,” said Lydia Abad-Franch, MD, MBA, Head of Research, Development, and Medical Affairs, and Chief Medical Officer at Sobi. “At EAHAD 2025, Sobi’s poster and oral presentations will demonstrate the important progress that has been made in the treatment of haemophilia A, as we continue to move the treatment paradigm towards normal haemostasis. We look forward to sharing our findings in Milan.”

View key data to be presented at EAHAD 2025 HERE.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.